TCMBANKIN003008 |
3-hydroxy-palmitic acid |
|
C16H31O3- |
271.42 g/mol |
CCCCCCCCCCCCCC(CC(=O)[O-])O |
TCMBANKIN004084 |
Thorn ginsenosides L |
|
|
|
|
TCMBANKIN004163 |
Caryophyleine-(I3) |
caryophyleine-(I3) |
|
204.39 |
|
TCMBANKIN004470 |
Thorn ginsenosides S |
|
|
|
|
TCMBANKIN005348 |
sosativene |
|
C15H24 |
|
CC(C)C1CCC2(C3C1CC(C3)C2=C)C |
TCMBANKIN005995 |
τ-cadinol |
|
|
|
|
TCMBANKIN006190 |
Thorn ginsenosides F |
|
|
|
|
TCMBANKIN006905 |
alpha-amorphene |
α-amorphene |
C15H24 |
204.35 |
|
TCMBANKIN007316 |
Thorn ginsenosides K |
|
|
|
|
TCMBANKIN007534 |
Thorn ginsenosides O |
|
|
|
|
TCMBANKIN007863 |
Thorn ginsenosides R |
|
|
|
|
TCMBANKIN007909 |
Thorn ginsenosides C |
|
|
|
|
TCMBANKIN008867 |
emodin ether |
|
C15H8O6 |
284.22 g/mol |
CC1=CC2=C(C(=C1)O)C(=C3C(=C4C(=O)C(=C3O)O4)C2=O)O |
TCMBANKIN010834 |
Thorn ginsenosides A |
|
|
|
|
TCMBANKIN011273 |
hedycaryol |
|
C15H26O |
222.37 g/mol |
CC1=CCCC(=CCC(CC1)C(C)(C)O)C |
TCMBANKIN011371 |
Thorn ginsenosides I |
|
|
|
|
TCMBANKIN011580 |
Thorn ginsenosides Q |
|
|
|
|
TCMBANKIN013834 |
bulnesol |
|
C15H26O |
222.37 g/mol |
CC1CCC2=C(CCC(CC12)C(C)(C)O)C |
TCMBANKIN014191 |
(+)-δ-cadinen |
|
C15H24 |
|
CC1=C2CC=C(CC2C(CC1)C(C)C)C |
TCMBANKIN014548 |
Thorn ginsenosides E |
|
|
|
|
TCMBANKIN014959 |
Thorn ginsenosides N |
|
|
|
|
TCMBANKIN015711 |
6,6-dimethyl-2-methylene-7-(3-oxobutylidene)oxepan-3-ylmethyl acetic acid ester |
|
|
280.4 |
|
TCMBANKIN016216 |
allocimeneB |
|
|
|
|
TCMBANKIN018201 |
4一o一caffeoylquinic acid |
|
|
|
|
TCMBANKIN019950 |
3-o-β-d-glucopyranosyl betulinicacid-28-o-β-d-glucopyranosyl-(1→6)-β-d-glucopyrano-side |
|
C48H78O18 |
|
|
TCMBANKIN021143 |
Sitosterol- 3- 0- β- D- glucopyranoside |
|
|
|
|
TCMBANKIN022145 |
(E)-3-nonene |
|
C9H18 |
126.24 g/mol |
CCCCCC=CCC |
TCMBANKIN022256 |
Thorn ginsenosides D |
|
|
|
|
TCMBANKIN022845 |
Thorn ginsenosides J |
|
|
|
|
TCMBANKIN022912 |
Thorn ginsenosides G |
|
|
|
|
TCMBANKIN023207 |
(2-amylphenyl)methanol |
(2-pentylphenyl)methanol |
C12H18O |
178.27 g/mol |
CCCCCC1=CC=CC=C1CO |
TCMBANKIN023306 |
Thorn ginsenosides H |
|
|
|
|
TCMBANKIN023323 |
τ-muurolol |
|
|
|
|
TCMBANKIN023676 |
tetracosanoic acid |
tetracosoate; tetracosanate; tetraeicosanoate; AC1NUU2A; 46927-71-3; tetracosanoate; n-tetracosanoate; DTXSID80420121; lignocerate; Lignocerat; CHEBI:31014; Tetracosanoat; CH3-[CH2]22-COO(-) |
C24H47O2- |
367.6 g/mol |
CCCCCCCCCCCCCCCCCCCCCCCC(=O)[O-] |
TCMBANKIN026021 |
α- bulnesene |
α-bulnesene |
|
|
|
TCMBANKIN028661 |
Thorn ginsenosides P |
|
|
|
|
TCMBANKIN029980 |
Thorn ginsenosides B |
|
|
|
|
TCMBANKIN030474 |
Rhubarb |
|
C61H50O30 |
1263 g/mol |
C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O.C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3OC4C(C(C(C(O4)CO)O)O)O)O.C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)O |
TCMBANKIN032653 |
Guaiol |
Spectrum3_001870; Guai-1(5)-en-11-ol; NSC19941; SCHEMBL18965701; C09676; 489-86-1; 448575_ALDRICH; Guaiac alcohol; 5-Azulenemethanol, 1,2,3,4,5,6,7,8-octahydro-.alpha.,.alpha.,3,8-tetramethyl-, [3S-(3.alpha.,5.alpha.,8.alpha.)]-; 2-[(3S,5R,8S)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl]propan-2-ol; 38730A; Champacol; [3S-(3alpha,5alpha,8alpha)]-1,2,3,4,5,6,7,8-octahydro-alpha,alpha,3,8-tetramethyl-5-azulenemethanol; (−)-Guaiol; CHEBI:5552; BSPBio_003320; guaiol; 50900_FLUKA; 29242_FLUKA; SPECTRUM1800009; (3R,6S,10S)-6,10,alpha,alpha-Tetramethylbicyclo[5.3.0]dec-1(7)-ene-3-methanol; Champaca camphor; KBio3_002822 |
C15H26O |
222.37 |
CC1CCC(CC2=C1CCC2C)C(C)(C)O |
TCMBANKIN033996 |
10,12-octadecadiynoicacid |
|
C18H28O2 |
276.4 g/mol |
CCCCCC#CC#CCCCCCCCCC(=O)O |
TCMBANKIN034767 |
Thorn ginsenosides M |
|
|
|
|
TCMBANKIN035440 |
dauricine |
AKOS015965146; AC-20217; SCHEMBL677474; 524-17-4 |
C38H44N2O6 |
624.77 |
CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC |
TCMBANKIN036173 |
trans-2-octena |
|
|
|
|
TCMBANKIN037001 |
alpha-Guaiene |
(1S,4S,7R)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,4,5,6,7,8-octahydroazulene; alpha-guaiene; α-guaiene; (1S,4S,7R)-7-isopropenyl-1,4-dimethyl-1,2,3,4,5,6,7,8-octahydroazulene |
C15H24 |
204.35 g/mol |
CC1CCC(CC2=C1CCC2C)C(=C)C |
TCMBANKIN037308 |
β-Eudesmol |
2-Naphthaleneethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-; SCHEMBL12633040; beta-eudesmol; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-decalin-2-yl]propan-2-ol; 17790_FLUKA; 2-Naphthalenemethanol, decahydro-8-methylene-alpha,alpha,4a-trimethyl-, (2R-(2-alpha,4a-alpha,8a-beta)-; 2-[(2R,4aR,8aS)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; 3beta-(1-Hydroxy-1-methylethyl)-5-methylene-8abeta-methyldecahydronaphthalene; Beta- Eudesmol; (2R,4aR,8aS)-Decahydro-8-methylene-alpha,alpha,4a-trimethyl-2-naphthylmethanol; β- eudesmol; Eudesm-4(14)-en-11-ol (8CI); beta-Selinenol; rel-2-[(2R,4aR,8aS)-4a-methyl-8-methylenedecahydronaphthalen-2-yl]propan-2-ol; 2-naphthalenemethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-, (2R,4aR,8aS)-; C09664; InChI=1/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12-13,16H,1,5-10H2,2-4H3/t12-,13+,15-/m1/s; beta-eudesmol ; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-2-decalinyl]propan-2-ol; AC1NSVC6; 2-[(2R,4aR)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; beta-Eudesmol; beta- eudesmol; 473-15-4; 4(15)-eudesmen-11-ol |
|
222.37 |
|
TCMBANKIN037382 |
Aloeemodin |
AC1Q6JR7; SMP2_000291; Aloe-emodol; 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone; DSSTox_RID_78855; AS-11638; NCGC00163510-02; HY-N0189; CCG-208456; Diacerein impurity B, European Pharmacopoeia (EP) Reference Standard; AJ-48016; DTXSID2030695; BC216172; TL8003252; 3-(Hydroxymethyl)chrysazin; MLS000697563; BBL027838; 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione; AK160272; 481-72-1; aloe emodine; MCULE-6965338444; RP29614; 1, 8-dihydroxy-3-hydroxymethylanthraquinone; BB_NC-2562; NCGC00255349-01; C10294; SR-01000765772; BG00617009; 9, 1,8-dihydroxy-3-(hydroxymethyl)-; ST24045939; DSSTox_CID_10695; Tox21_302400; NCGC00163510-03; Anthraquinone,8-dihydroxy-3-(hydroxymethyl)-; 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone #; 1,8-Dihydroxy-3-hydroxymethyl-9,10-anthracenedione, 9CI; Aloeemodin; s2259; CS-3709; TR-031339; 1,8-Dihydroxy-3-hydroxymethylanthraquinone; 4-08-00-03578 (Beilstein Handbook Reference); AIDS-048396; InChI=1/C15H10O5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18H,6H; 1,8-dihydroxy-3-(hydroxymethyl)-9,10-anthrachinon; CAS-481-72-1; EINECS 207-571-7; UNII-C8IYT9CR7C; LMPK13040002; AC-020; NSC-38628; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-hydroxymethyl-anthracene; 1,8-dihydroxy-3-methylol-9,10-anthraquinone; CCRIS 3526; AC1L1UPK; BG01563188; LS-2202; 1,8-dihydroxy-3-hydroxymethyl-anthraquinone; Aloe emodin; AX8006287; SR-01000765772-3; Q-100526; SC-46578; 3-Hydroxymethylchrysazin; Rhabarberone; AIDS048396; NSC 38628; BRN 2059062; C8IYT9CR7C; N1851; 1,8-Dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione; AB0010470; Aloe-emodin, >=95% (HPLC); ZINC4098644; aloe emodin; HMS3655N16; D09BUG; CHEMBL40275; 1,8-Dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (Aloe-Emodin); NCGC00163510-01; MLS006011799; 1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone; AN-16215; NCI60_003685; Aloeemodin:9,10-Anthracenedione,1,8-dihydroxy-3-(hydroxymethyl)-,; cid_10207; 3-Hydroxymethylchrysazine; Aloe-emodin; SMR000470920; aloeemod-in; MFCD00017373; LMPK02000031; STL146380; 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-; MolPort-003-931-716; FT-0622062; aloe-emodin; API0001418; 1,8-dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone; Rottlerin?; ANTHRAQUINONE, 1,8-DIHYDROXY-3-HYDROXYMETHYL-; A7687_SIGMA; I14-1413; 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)- (9CI); CA-417; BDBM50085551; Aloe-emodine; YDQWDHRMZQUTBA-UHFFFAOYSA-N; NSC38628; Aloe-emodin, analytical standard; AKOS005720864; aloe-emodin ; SCHEMBL309756; 481A721; EMODINE; Anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-; CHEBI:2607; DSSTox_GSID_30695; CA0128 |
|
270.24 |
|
TCMBANKIN037541 |
alpha-Cubebene |
α-cubebene; α- cubebene; 17699-14-8; alpha-cubebene; C09647 |
C15H24 |
204.351 |
C([H])([H])([H])[C@@]1([H])[C@@]2([C@]3([H])C(C([H])([H])[H])=C([H])C2([H])[H])[C@@]3([H])[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H] |
TCMBANKIN038532 |
δ-Cadinene |
δ- cadinene |
|
204.39 |
|
TCMBANKIN039530 |
Cirenshenoside S |
|
|
1105.3 g/mol |
|
TCMBANKIN039554 |
hexanoic acid |
(C6-C12) Alkylcarboxylic acid; n-Hexoic acid; BRN 0773837; Hexanoyl DL-carnitine; AC1O52RE; hexanoicacid; 142-62-1; Hexanoic acid (natural); n-Hexanoic acid; CCRIS 1347; Hexacid 698; 153745_ALDRICH; Hexanoic acid; 13476-79-4; 8040-17-3; 51109-46-7; AI3-07701; WLN: QV5; VVPRQWTYSNDTEA-UHFFFAOYSA-N; 19455-00-6; (C5-C9) Monobasic acids; Pentylformic acid; Hexanoyl-d,l-carnitine; Capronic acid; Butylacetic acid; Kyselina kapronova [Czech]; 4-02-00-00917 (Beilstein Handbook Reference); C01585; 1-Pentanecarboxylic acid; UN2829; 3-hexanoyloxy-4-(trimethylazaniumyl)butanoate; Fatty acids, C6-12; (C6-C12)Alkylcarboxylic acid; W255912_ALDRICH; NSC8266; CAPROIC ACID; CH3-[CH2]4-COOH; LMFA01010006; HEXANOIC ACID (CAPROIC ACID); n-Caproic acid; EINECS 267-013-3; CHEBI:30776; Hexanoylcarnitine; 68603-84-9; 70248-25-8; 21529_FLUKA; HSDB 6813; 3-(hexanoyloxy)-4-(trimethylazaniumyl)butanoate; Carboxylic acids, C5-9; NSC 8266; NCIOpen2_005355; LMFA07070070; 1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, chloride (1:1); EINECS 205-550-7; SCHEMBL235082; 1-Hexanoic acid; Pentanecarboxylic acid; Acid C-6; Carboxylic acids, C6-18 and C6-18-unsatd. mono- and C8-15-di-; H12137_ALDRICH; W255904_ALDRICH; 16571-42-9; Hexylic acid; AIDS212980; Caproic acid [UN2829] [Corrosive]; FEMA No. 2559; 67762-36-1; n-Hexylic acid; Hexoic acid; Pentiformic acid; EINECS 274-509-3; 6418-78-6; AIDS-212980; 53896-26-7; CTK4C6070; EINECS 271-676-4; Hexanoic acid ester with (3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt; CHEBI:70749; InChI=1/C6H12O2/c1-2-3-4-5-6(7)8/h2-5H2,1H3,(H,7,8; O-hexanoylcarnitine; 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, inner salt; 3-(hexanoyloxy)-4-(trimethylammonio)butanoate |
C6H12O2 |
116.158 |
C(O[H])(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
TCMBANKIN040702 |
Globulol |
viridiflorol |
C15H26O |
222.366 |
[C@@]1(C([H])([H])[H])(O[H])C([H])([H])C([H])([H])[C@@]([H])(C2(C([H])([H])[H])C([H])([H])[H])[C@]2([H])[C@]([H])([C@@]([H])(C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]13[H] |
TCMBANKIN040797 |
azelaic acid |
8-carboxylatooctanoate; CJ-24076; 9-oxido-9-oxononanoate; AC1MWLWR; azelaate(2-); azelaicacid; 8-Carboxyoctanoate; CHEBI:78208; nonanedioate(2-); azelate; nonanedioate; azelaate; A805183 |
C9H16O4 |
188.221 |
C([H])([H])(C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O |
TCMBANKIN040900 |
Bornyl acetate |
B0526; 5655-61-8; BORNYL ACETATE; ( )-Bornyl acetate; bornylacetate |
|
196.29 g/mol |
|
TCMBANKIN040905 |
cirenshenoside v |
|
C48H76O19 |
|
|
TCMBANKIN041815 |
3-epi-oleanolic acid-28-o-alpha-l-rhamno-pyranosyl-(1-b58666)-beta-d-glucopyranoside |
|
|
|
|
TCMBANKIN042440 |
Cirenshenoside U |
|
|
|
|
TCMBANKIN043469 |
γ-Elemene |
O-Menth-8-ene, 4-isopropylidene-1-vinyl-; 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-cyclohexane; γ- elemene; γ--elemene; γ-Elernene |
|
204.35 |
|
TCMBANKIN044259 |
(+)-sativen |
|
C15H24 |
204.351 |
C(=C([H])[H])([C@]([H])(C([H])([H])C1([H])[H])[C@]12C([H])([H])[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C3([H])[H])[C@]23C([H])([H])[H] |
TCMBANKIN044314 |
cirenshenoside t |
|
C54H88O23 |
|
|
TCMBANKIN045695 |
7alpha-L-Rhamnosyl-6-methoxylutcolin |
7alpha-l-rhamnosyl-6-methoxylutcolin |
C22H22O11 |
462.403 |
c1(O[C@@]([H])(O[C@@]2([H])C([H])([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c([H])c(OC(c3c([H])c([H])c(O[H])c(O[H])c3[H])=C([H])C4=O)c4c(O[H])c1OC([H])([H])[H] |
TCMBANKIN046249 |
camphene |
CHEMBL506889; CJ-04639; (-)-camphene; (-)-Camphene, technical grade, 75% (90% as camphene and fenchene); L-Camphene; DSSTox_RID_81702; (1S,4R)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane; Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, (1S)-; (1S)-2,2-Dimethyl-3-methylenebicyclo(2.2.1)heptane; DSSTox_CID_26538; FCH1121419; (1S,4R)-2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane; 5794/4/7; C06305; (-) camphene; ZB015525; CC-00037; M5YAV509FN; UNII-G3VG94Z26E component CRPUJAZIXJMDBK-BDAKNGLRSA-N; DTXSID3046538; ZINC968230; CHEBI:89; (1S,4R)-camphene; (-)-Comphene; cam phene; DSSTox_GSID_46538; NCGC00166100-01; (-)-(1S,4R)-camphene; Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, (1S,4R)-; CAS-5794-04-7; EINECS 227-337-8; UNII-M5YAV509FN; CRPUJAZIXJMDBK-BDAKNGLRSA-N; (1S)-2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane; Tox21_112314 |
C10H16 |
136.23 g/mol |
CC1(C2CCC(C2)C1=C)C |
TCMBANKIN048392 |
alpha-eudesmol |
92480-60-9; 2-[(2R,4aR,8aR)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]propan-2-ol; 75684-39-8; C09663; 473-16-5; α-eudesmol; 2-Naphthalenemethanol, 1,2,3,4,4a,5,6,8a-octahydro-alpha,alpha,4a,8-tetramethyl-, (2R,4aR,8aR)-; alpha-eudesmol |
C15H26O |
222.366 |
[C@@]1([H])(C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[C@@]([H])(C(C([H])([H])[H])=C([H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H] |
TCMBANKIN048728 |
longifolene-(v4) |
|
C15H24 |
204.35 g/mol |
CC1(CC=CC2(C3C1CC2(CC3)C)C)C |
TCMBANKIN057949 |
sucrose |
Amerfand; 29253-78-9; Sucrose (TN); alpha-D-Glucopyranoside, beta-D-fructofuranosyl-; saccharose; Sugar, compressible (NF); S0389_SIGMA; D06530; C00089; 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside; Sucrose, purified; 8027-47-2; 30027-72-6; 29764-06-5; 86101-30-6; NSC 406942; D06529; Sucrose [USAN:JAN]; 146187-04-4; ST5308554; Sugar, confectioner's; D(+)-Saccharose; S7903_SIGMA; GLC-(1-2)FRU; alpha-D-glucopyranosyl beta-D-fructofuranoside; FICOLL; 151756-02-4; Sugar spheres (NF); White soft sugar (JP15); Sucraloxum [INN-Latin]; Saccharum; alpha-D-Glc-(1-2)-beta-D-Fru; S9378_SIGMA; 76056-38-7; 47289_SUPELCO; D-Sucrose; Sugar spheres; 87430-66-8; 104242-10-6; (alpha-D-Glucosido)-beta-D-fructofuranoside; Table sugar; Sacharose; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; NCI-C56597; 47167-52-2; CCRIS 2120; alpha-D-Glucopyranoside, beta-D-fructofuranosyl, homopolymer; D06528; Microse; Cane sugar; Amerfond; 64533-66-0; White soft sugar; beta-D-Fruf-(2<->1)-alpha-D-Glcp; sugar; White sugar; SUC; 84097_FLUKA; Rock candy; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; Fructofuranoside, alpha-D-glucopyranosyl, beta-D; 80165-03-3; 47257-91-0; CHEBI:17992; 47185-09-1; S5390_SIGMA; alpha-D-Glucopyranoside, beta-D-fructofuranosyl; S1888_SIGMA; 220376-22-7; D06533; 8030-20-4; S3929_SIGMA; S1174_SIGMA; 65545-99-5; Glucopyranoside, beta-D-fructofuranosyl, alpha-D; S2395_SIGMA; 78654-77-0; D06531; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; SUCROSE; S5016_SIAL; 51909-69-4; 85456-51-5; D()-Saccharose; ZINC04217475; 84100_FLUKA; D00025; Confectioner's sugar; EINECS 200-334-9; Sugar, confectioner's (NF); 57-50-1; 100405-08-1; 92004-84-7; Beet sugar; S5391_SIGMA; Sucrose, dust; alpha-D-Glc-(1->2)-beta-D-Fru; beta-D-Fructofuranosyl alpha-D-glucopyranoside; 131932-12-2; HSDB 500; Sugar, compressible; AI3-09085; alpha-D-Glucopyranosylbeta-D-fructofuranoside; Rohrzucker; 16104_RIEDEL; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; Granulated sugar; S8501_SIGMA; Sucrose, purified (JAN); 146054-35-5; Sucrose (JP15/NF); 9012-95-7; Sucrose, pure; 75398-84-4; 50857-68-6; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 25702-74-3; D(+)-Sucrose |
C12H22O11 |
342.3 g/mol |
C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O |
TCMBANKIN058683 |
2-[(1R,3S,4S)-3-isopropenyl-4-methyl-4-vinylcyclohexyl]propan-2-ol |
EINECS 211-360-5; 2-[(1R,3S,4S)-4-ethenyl-4-methyl-3-prop-1-en-2-ylcyclohexyl]propan-2-ol; 8024-27-9; AI3-00210; Cyclohexanemethanol, 4-ethenyl-alpha,alpha,4-trimethyl-3-(1-methylethenyl)-, (1R,3S,4S)-; Cyclohexanemethanol, 4-ethenyl-alpha,alpha,4-trimethyl-3-(1-methylethenyl)-, (1R-(1alpha,3alpha,4beta))-; 2-[(1R,3S,4S)-4-ethenyl-4-methyl-3-prop-1-en-2-yl-cyclohexyl]propan-2-ol; 639-99-6; Cyclohexanemethanol, 4-ethenyl-alpha,alpha,4-trimethyl-3-(1-methylethenyl)-, (1theta-(1alpha,3alpha,4beta))-; 2-[(1R,3S,4S)-3-isopropenyl-4-methyl-4-vinyl-cyclohexyl]propan-2-ol; (1S,2S,4R)-(-)-alpha,alpha-Dimethyl-1-vinyl-o-menth-8-ene-4-methanol;Elemol;elemol; GFJIQNADMLPFOW-GUTXKFCHSA-N; [1R-[1.alpha.,3.alpha.,4.beta.]]-4-Ethenyl-.alpha.,.alpha.,4-trimethyl-3-[1-methylethenyl]cyclohexanemethanol |
C15H26O |
222.37 |
CC(=C)C1CC(CCC1(C)C=C)C(C)(C)O |
TCMBANKIN058707 |
3-epi-betulinicacid acetate |
acetylbetulinicacid |
C32H50O4 |
498.7 g/mol |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C)C)C(=O)O |
TCMBANKIN058725 |
1-ethenyl-1-methy-2-(1-methylethenyl)-4-(methylethylldene)-cyclohexane |
elixene;cyclohexane,1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-;elixen;gamma-elemene;.gamma.-Elemene |
C15H24 |
204.35 g/mol |
CC(=C1CCC(C(C1)C(=C)C)(C)C=C)C |
TCMBANKIN058761 |
(E)ocimene |
(E)- ocimene; (E)-ocimene;p-Ocimene;3,7-Dimethyl-1,3,6-octatriene;trans-ocimene;trans- beta- Ocimene;ocimene;β-trans-ocimene;3,7-dimethyl-1,3e,6-octatriene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;trans-β-Oci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;ci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene |
C10H16 |
136.23 g/mol |
CC(=CCC=C(C)C=C)C |
TCMBANKIN058816 |
beta-myrcene |
7-Methyl-3-methylene-octa-1,6-diene; DSSTox_RID_77883; Q-201417; CJ-23958; Myrcene, >=95%, stabilized, FCC, FG; A805060; MYRCENE, TECH; 123-35-3; STL477735; FEMA 2762; AN-22914; beta-geraniolene; LS-678; 7-Methyl-3-methylene-1,6-octadiene (myrcene); AK116901; V0542; AI3-00738; .beta.-Myrcene; 7-Methyl-3-methylene-1,6-octadiene (beta -myrcene); Myrcene, analytical standard; NCGC00254252-01; NSC-406264; ST24029965; 7-?Methyl-?3-?methylene-?1,6-?octadiene; RP20298; C06074; NCGC00091420-02; CHEBI:17221; AC1Q1NVC; Tox21_300351; MYRCENE; 2153-31-3; DSSTox_CID_5692; Jsp001569; FEMA No. 2762; FCH1116940; beta -mircene; beta -myrcene; 7-methyl-3-methylidene-octa-1,6-diene; 7-methyl-3-methylideneocta-1,6-diene; β-myrcene; Myrcene (stabilized with BHT); 2-Methyl-6-methylene-2,7-octadiene; BRN 1719990; WLN: 1Y1&U3YU1&1U1; beta- Myrcene; UAHWPYUMFXYFJY-UHFFFAOYSA-N; 7-Methyl-3-methyleneoctadiene-(1,6); 3-Methylene-7-methyl-1, 6-octadiene; NCGC00091420-01; Mycrene Solution, 1000 mg/L, 1 ml (RM, ISO Guide 34); EINECS 204-622-5; DTXSID6025692; DSSTox_GSID_25692; β- myrcene; Myrcene, technical grade; beta-Myrcene; MYRCENE 90; LMPR0102010005; Myrcene, primary pharmaceutical reference standard; NSC 406264; KS-00000WLP; HSDB 1258; AC1Q1J8N; Myrcene, .beta.-; 3M39CZS25B; beta-Myrcene (>90%); TR-003681; AJ-26651; ZINC1530331; FT-0629050; CHEMBL455491; UNII-3M39CZS25B; NSC406264; MolPort-001-792-515; beta-myrcene ; I14-17984; CCRIS 3725; 7-methyl-3-methylene-1,6 octadiene; C-34801; M0235; AKOS015904015; CAS-123-35-3; AC1L1L8S; .beta.-Geraniolene; 7-Methyl-3-methyleneocta-1,6-diene; CC-31053; b-Geraniolene; 7-Methyl-3-methylene-1,6-octadiene; 4-01-00-01108 (Beilstein Handbook Reference); Myrcene (natural); EC 204-622-5; MFCD00008908; b-Myrcene; 1,6-Octadiene, 7-methyl-3-methylene-; 3-Methylene-7-methyl-1,6-octadiene; InChI=1/C10H16/c1-5-10(4)8-6-7-9(2)3/h5,7H,1,4,6,8H2,2-3H; 1, 7-methyl-3-methylene- |
C10H16 |
136.23 g/mol |
CC(=CCCC(=C)C=C)C |
TCMBANKIN058819 |
Citralva |
3,7-Dimethylocta-2,6-dienenitrile; 80748-12-5; 5146-66-7; Geranonitrile; W512508_ALDRICH; 157678_ALDRICH; EINECS 225-918-0; Geranyl nitrile; NSC109052; (2E)-3,7-dimethylocta-2,6-dienenitrile; 5585-39-7; 2-Geranonitrile; (E)-3,7-Dimethyl-2,6-octadienenitrile; ZINC01701190; EINECS 226-982-2; 2,6-Octadienenitrile, 3,7-dimethyl-, (2E)-; Gerano nitrile 1; ST5308599; 2,6-OCTADIENENITRILE, 3,7-DIMETHYL-, (E)-; 3,7-Dimethyl-2,6-octadienenitrile; 80655-58-9; 2,6-Octadienenitrile, 3,7-dimethyl-; geranylnitrile |
C10H15N |
149.23 g/mol |
CC(=CCCC(=CC#N)C)C |
TCMBANKIN058842 |
trans nerolidol; |
3,7,11-trimethyl-1,6,10-dodecatrien-3-ol; Trans- nerolidol; .+/-.-trans-Nerolidol; 1,6,10-Dodecatrien-3-ol,3,7,11-trimethyl-,(E)-; trans-Nerolidol |
C15H26O |
222.37 g/mol |
CC(=CCCC(=CCCC(C)(C=C)O)C)C |
TCMBANKIN059502 |
1H-Cycloprop(e)azulen-7-ol, decahydro-1,1,7-trimethyl-4-methylene-, (1aR-(1aalpha,4aalpha,7beta,7abeta,7balpha))- |
|
C15H24O |
220.35 |
CC1(C2C1C3C(CCC3(C)O)C(=C)CC2)C |
TCMBANKIN059521 |
B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene |
|
C10H16 |
136.23 g/mol |
CC1(C2CCC(=C)C1C2)C |
TCMBANKIN059527 |
(+)-Camphene |
|
C10H16 |
136.23 g/mol |
CC1(C2CCC(C2)C1=C)C |
TCMBANKIN059762 |
26-o-β-d-glucopyranosyl(25r,s)-5α-furo-stane-12-one-20(22)-en-3β,26-diol-3-o-β-d-glucopyranosyl-(1→4)-β-d-galactopyranoside |
|
C45H72O19 |
|
CC1=C(OC2C1C3(C(C2)C4CCC5CC(CCC5(C4CC3=O)C)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)O)O)O)O)C)CCC(C)COC8C(C(C(C(O8)CO)O)O)O |
TCMBANKIN059921 |
o- Cymene |
|
C10H14 |
134.22 g/mol |
CC1=CC=CC=C1C(C)C |
TCMBANKIN059928 |
emodin |
|
C15H10O5 |
270.24 g/mol |
CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O |
TCMBANKIN059960 |
(-)-g-cadinene |
|
C15H24 |
204.35 g/mol |
CC1=CC2C(CC1)C(=C)CCC2C(C)C |
TCMBANKIN059962 |
cadinen;α-Cadinene;1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)naphthalene;1,2,4A,5,6,8A-hexahydro--4,7-dimethyl-(1-methylethyl)-naphthalene;muurolene;1,2,4a,5,6,8a- hexhydro- 4,7- dimethyl- 1-(1- methylethyl)-(1alpha 4a. alpha.,8a alpha. )- naphthalene;alpha cadinene;α-muurolene |
|
C15H24 |
204.35 g/mol |
CC1=CC2C(CC1)C(=CCC2C(C)C)C |
TCMBANKIN059963 |
naphthalene,1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-,(1S-cis)-;Naphthalene, 1, 2, 3, 5, 6, 8a-hexahydro-4, 7-dimethyl-1-(1-methylethyl)-,(1S-cis);δ-cadinol |
|
C15H24;C10H18 |
204.35 g/mol |
CC1=CC2C(CCC(=C2CC1)C)C(C)C |
TCMBANKIN059964 |
α-cadinol |
|
C15H26O |
222.37g/mol |
CC1=CC2C(CCC(C2CC1)(C)O)C(C)C |
TCMBANKIN059974 |
alpha-phellandrene |
|
C10H16 |
136.23 |
CC1=CCC(C=C1)C(C)C |
TCMBANKIN059982 |
d-limonene |
|
C10H16 |
136.23 g/mol |
CC1=CCC(CC1)C(=C)C |
TCMBANKIN060009 |
copaene; (-)-Alpha-Copaene; α-copaene |
|
C15H24 |
204.35 g/mol |
CC1=CCC2C3C1C2(CCC3C(C)C)C |
TCMBANKIN060012 |
alpha-bergamotene |
|
C15H24 |
204.35 g/mol |
CC1=CCC2CC1C2(C)CCC=C(C)C |
TCMBANKIN060015 |
9-epi-(E)-caryophyllene |
|
C15H24 |
204.35 g/mol |
CC1=CCCC(=C)C2CC(C2CC1)(C)C |
TCMBANKIN060021 |
hedycaryol |
|
C15H26O |
222.37 g/mol |
CC1=CCCC(=CCC(CC1)C(C)(C)O)C |
TCMBANKIN060032 |
alpha-Eudesmol |
|
C15H26O |
222.37 |
CC1=CCCC2(C1CC(CC2)C(C)(C)O)C |
TCMBANKIN060145 |
rhamnose |
|
C6H12O5 |
164.16 g/mol |
CC1C(C(C(C(O1)O)O)O)O |
TCMBANKIN060227 |
pulsatiloside c |
|
C48H78O18 |
943.1 g/mol |
CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)CO)O)C)(C)C)O)O)O)CO)O)O)O |
TCMBANKIN060332 |
thujene |
|
C10H16 |
136.23 g/mol |
CC1C=CC2(C1C2)C(C)C |
TCMBANKIN060458 |
cubenol |
|
C15H26O |
222.37 |
CC1CCC(C2C1(CCC(=C2)C)O)C(C)C |
TCMBANKIN060468 |
(+)-calaren |
|
C15H24 |
204.35 |
CC1CCC=C2C1(C3C(C3(C)C)CC2)C |
TCMBANKIN060565 |
ledene |
|
C15H24 |
204.35 g/mol |
CC1CCC2=C(CCC3C(C12)C3(C)C)C |
TCMBANKIN060593 |
()-Aromadendrene;(+)-aromadendrene |
|
C15H24 |
204.35 |
CC1CCC2C1C3C(C3(C)C)CCC2=C |
TCMBANKIN060693 |
Sitogluside |
|
C35H60O6 |
576.85g/mol |
CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |
TCMBANKIN060867 |
(3E,5E )-1,3,5-Undeca-triene |
|
C11H18 |
150.26 g/mol |
CCCCCC=CC=CC=C |
TCMBANKIN060888 |
caproaldehyde |
|
C6H12O |
100.16 g/mol |
CCCCCC=O |
TCMBANKIN060898 |
heptanoic acid;heptylic acid;enanthylic acid |
|
CH3(CH2)5COOH |
130.18 |
CCCCCCC(=O)O |
TCMBANKIN060914 |
11-Octadecenoic acid |
|
C18H34O2 |
282.5 g/mol |
CCCCCCC=CCCCCCCCCCC(=O)O |
TCMBANKIN060918 |
WLN: VH6 |
|
C7H14O |
114.19 |
CCCCCCC=O |
TCMBANKIN060934 |
dec-2-enal |
|
C10H18O |
154.25g/mol |
CCCCCCCC=CC=O |
TCMBANKIN061001 |
2-TRIDECENAL |
|
C13H24O |
196.33 g/mol |
CCCCCCCCCCC=CC=O |
TCMBANKIN061170 |
heptadecanol |
|
C17H36O |
256.47 |
CCCCCCCCCCCCCCCCCO |
TCMBANKIN061792 |
syringin |
C17H24O9; Glucoside, 4-(3-hydroxypropenyl)-2,6-dimethoxyphenyl, D; beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl; LS-172368; Ligustrin (VAN); NSC 287441;syringenone;Syrigin;cis-syringin;ligustrin |
C17H24O9 |
372.4 g/mol |
COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C=CCO |